The management of bone metastases and hypercalcaemia by osteoclast inhibition: an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Toronto u.a.
Hogrefe & Huber
1990
|
| Schlagworte: | |
| Beschreibung: | 123 S. Ill. |
| ISBN: | 0889370478 3456819226 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV004502788 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 910913s1990 a||| |||| 10||| engod | ||
| 020 | |a 0889370478 |9 0-88937-047-8 | ||
| 020 | |a 3456819226 |9 3-456-81922-6 | ||
| 035 | |a (OCoLC)22110124 | ||
| 035 | |a (DE-599)BVBBV004502788 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-11 | ||
| 050 | 0 | |a RC280.B6 | |
| 082 | 0 | |a 616.99/271 |2 20 | |
| 245 | 1 | 0 | |a The management of bone metastases and hypercalcaemia by osteoclast inhibition |b an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 |c Robert D. Rubens, ed. |
| 264 | 1 | |a Toronto u.a. |b Hogrefe & Huber |c 1990 | |
| 300 | |a 123 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Hypercalcémie - Chimiothérapie - Congrès | |
| 650 | 4 | |a Métastases osseuses - Chimiothérapie - Congrès | |
| 650 | 4 | |a Ostéoclastes - Inhibition - Congrès | |
| 650 | 4 | |a Pamidronate disodique - Congrès | |
| 650 | 4 | |a Résorption osseuse - Chimiothérapie - Congrès | |
| 650 | 4 | |a Bone Neoplasms |x secondary |v Congresses | |
| 650 | 4 | |a Bone metastasis |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Bone resorption |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Diphosphonates |x therapeutic use |v Congresses | |
| 650 | 4 | |a Disodium pamidronate |v Congresses | |
| 650 | 4 | |a Hypercalcemia |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Hypercalcemia |x drug therapy |v Congresses | |
| 650 | 4 | |a Hypercalcemia |x etiology |v Congresses | |
| 650 | 4 | |a Osteoclast inhibition |v Congresses | |
| 650 | 4 | |a Osteoclasts |x drug effects |v Congresses | |
| 650 | 0 | 7 | |a Hyperkalzämie |0 (DE-588)4239846-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pamidronsäure |0 (DE-588)4242256-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Knochenmetastase |0 (DE-588)4164290-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z London |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Hyperkalzämie |0 (DE-588)4239846-0 |D s |
| 689 | 0 | 2 | |a Pamidronsäure |0 (DE-588)4242256-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Knochenmetastase |0 (DE-588)4164290-9 |D s |
| 689 | 1 | 1 | |a Pamidronsäure |0 (DE-588)4242256-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Rubens, Robert D. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-002777375 | ||
Datensatz im Suchindex
| _version_ | 1804118648069029888 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV004502788 |
| callnumber-first | R - Medicine |
| callnumber-label | RC280 |
| callnumber-raw | RC280.B6 |
| callnumber-search | RC280.B6 |
| callnumber-sort | RC 3280 B6 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)22110124 (DE-599)BVBBV004502788 |
| dewey-full | 616.99/271 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/271 |
| dewey-search | 616.99/271 |
| dewey-sort | 3616.99 3271 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02474nam a2200613 c 4500</leader><controlfield tag="001">BV004502788</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">910913s1990 a||| |||| 10||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0889370478</subfield><subfield code="9">0-88937-047-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3456819226</subfield><subfield code="9">3-456-81922-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)22110124</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004502788</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC280.B6</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/271</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The management of bone metastases and hypercalcaemia by osteoclast inhibition</subfield><subfield code="b">an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989</subfield><subfield code="c">Robert D. Rubens, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Toronto u.a.</subfield><subfield code="b">Hogrefe & Huber</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">123 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypercalcémie - Chimiothérapie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Métastases osseuses - Chimiothérapie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ostéoclastes - Inhibition - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pamidronate disodique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Résorption osseuse - Chimiothérapie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bone Neoplasms</subfield><subfield code="x">secondary</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bone metastasis</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bone resorption</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diphosphonates</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Disodium pamidronate</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypercalcemia</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypercalcemia</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypercalcemia</subfield><subfield code="x">etiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Osteoclast inhibition</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Osteoclasts</subfield><subfield code="x">drug effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperkalzämie</subfield><subfield code="0">(DE-588)4239846-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pamidronsäure</subfield><subfield code="0">(DE-588)4242256-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Knochenmetastase</subfield><subfield code="0">(DE-588)4164290-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">London</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Hyperkalzämie</subfield><subfield code="0">(DE-588)4239846-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pamidronsäure</subfield><subfield code="0">(DE-588)4242256-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Knochenmetastase</subfield><subfield code="0">(DE-588)4164290-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pamidronsäure</subfield><subfield code="0">(DE-588)4242256-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rubens, Robert D.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002777375</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1989 London gnd-content |
| genre_facet | Konferenzschrift 1989 London |
| id | DE-604.BV004502788 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:13:38Z |
| institution | BVB |
| isbn | 0889370478 3456819226 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002777375 |
| oclc_num | 22110124 |
| open_access_boolean | |
| owner | DE-12 DE-11 |
| owner_facet | DE-12 DE-11 |
| physical | 123 S. Ill. |
| publishDate | 1990 |
| publishDateSearch | 1990 |
| publishDateSort | 1990 |
| publisher | Hogrefe & Huber |
| record_format | marc |
| spelling | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 Robert D. Rubens, ed. Toronto u.a. Hogrefe & Huber 1990 123 S. Ill. txt rdacontent n rdamedia nc rdacarrier Hypercalcémie - Chimiothérapie - Congrès Métastases osseuses - Chimiothérapie - Congrès Ostéoclastes - Inhibition - Congrès Pamidronate disodique - Congrès Résorption osseuse - Chimiothérapie - Congrès Bone Neoplasms secondary Congresses Bone metastasis Chemotherapy Congresses Bone resorption Chemotherapy Congresses Diphosphonates therapeutic use Congresses Disodium pamidronate Congresses Hypercalcemia Chemotherapy Congresses Hypercalcemia drug therapy Congresses Hypercalcemia etiology Congresses Osteoclast inhibition Congresses Osteoclasts drug effects Congresses Hyperkalzämie (DE-588)4239846-0 gnd rswk-swf Pamidronsäure (DE-588)4242256-5 gnd rswk-swf Knochenmetastase (DE-588)4164290-9 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1989 London gnd-content Krebs Medizin (DE-588)4073781-0 s Hyperkalzämie (DE-588)4239846-0 s Pamidronsäure (DE-588)4242256-5 s DE-604 Knochenmetastase (DE-588)4164290-9 s Rubens, Robert D. Sonstige oth |
| spellingShingle | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 Hypercalcémie - Chimiothérapie - Congrès Métastases osseuses - Chimiothérapie - Congrès Ostéoclastes - Inhibition - Congrès Pamidronate disodique - Congrès Résorption osseuse - Chimiothérapie - Congrès Bone Neoplasms secondary Congresses Bone metastasis Chemotherapy Congresses Bone resorption Chemotherapy Congresses Diphosphonates therapeutic use Congresses Disodium pamidronate Congresses Hypercalcemia Chemotherapy Congresses Hypercalcemia drug therapy Congresses Hypercalcemia etiology Congresses Osteoclast inhibition Congresses Osteoclasts drug effects Congresses Hyperkalzämie (DE-588)4239846-0 gnd Pamidronsäure (DE-588)4242256-5 gnd Knochenmetastase (DE-588)4164290-9 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4239846-0 (DE-588)4242256-5 (DE-588)4164290-9 (DE-588)4073781-0 (DE-588)1071861417 |
| title | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 |
| title_auth | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 |
| title_exact_search | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 |
| title_full | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 Robert D. Rubens, ed. |
| title_fullStr | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 Robert D. Rubens, ed. |
| title_full_unstemmed | The management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 Robert D. Rubens, ed. |
| title_short | The management of bone metastases and hypercalcaemia by osteoclast inhibition |
| title_sort | the management of bone metastases and hypercalcaemia by osteoclast inhibition an international symposium held during the 5th european conference on clinical oncology ecco 5 london september 1989 |
| title_sub | an international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989 |
| topic | Hypercalcémie - Chimiothérapie - Congrès Métastases osseuses - Chimiothérapie - Congrès Ostéoclastes - Inhibition - Congrès Pamidronate disodique - Congrès Résorption osseuse - Chimiothérapie - Congrès Bone Neoplasms secondary Congresses Bone metastasis Chemotherapy Congresses Bone resorption Chemotherapy Congresses Diphosphonates therapeutic use Congresses Disodium pamidronate Congresses Hypercalcemia Chemotherapy Congresses Hypercalcemia drug therapy Congresses Hypercalcemia etiology Congresses Osteoclast inhibition Congresses Osteoclasts drug effects Congresses Hyperkalzämie (DE-588)4239846-0 gnd Pamidronsäure (DE-588)4242256-5 gnd Knochenmetastase (DE-588)4164290-9 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Hypercalcémie - Chimiothérapie - Congrès Métastases osseuses - Chimiothérapie - Congrès Ostéoclastes - Inhibition - Congrès Pamidronate disodique - Congrès Résorption osseuse - Chimiothérapie - Congrès Bone Neoplasms secondary Congresses Bone metastasis Chemotherapy Congresses Bone resorption Chemotherapy Congresses Diphosphonates therapeutic use Congresses Disodium pamidronate Congresses Hypercalcemia Chemotherapy Congresses Hypercalcemia drug therapy Congresses Hypercalcemia etiology Congresses Osteoclast inhibition Congresses Osteoclasts drug effects Congresses Hyperkalzämie Pamidronsäure Knochenmetastase Krebs Medizin Konferenzschrift 1989 London |
| work_keys_str_mv | AT rubensrobertd themanagementofbonemetastasesandhypercalcaemiabyosteoclastinhibitionaninternationalsymposiumheldduringthe5theuropeanconferenceonclinicaloncologyecco5londonseptember1989 |